A Randomized Standard Controlled Clinical Trial of Unani Topical Formulation in the Management of Dermatomycoses

Author:

Ahmad Zamir

Abstract

Dermatomycoses are the human’s oldest recognized and reported infections, which are the fastest growing infections of the skin, hair, and nails. These infections are a global concern due to their ever-increasing prevalence of about 25-27 %, high rate of relapse/recurrence, and resistance. The study was conducted in search of safer and more effective natural medicine. The effect of the standard drug, Terbinafine cream as control is compared with the test drug, Unani formulation in the paste form for local application, containing Kaththa (Acacia catechu), Hena (Lawsonia innermis), Mazu (Quercus infectoria), Kibreet (Sulphur), and Suhaga (Borax). The data on the effect of the control and test drugs on the various features of the dermatomycoses shows that the Unani formulation is almost similar to the standard drug in terms of Mycological cure and Clinical cure statistically. Hence, Unani formulation can be used in the treatment of dermatomycoses.

Publisher

Informatics Publishing Limited

Subject

Pharmacology

Reference20 articles.

1. Nenoff P, Krüger C, Ginter-Hanselmayer G, Tietz H-J. Mycology–An update. Part 1: Dermatomycoses: Causative agents, epidemiology and pathogenesis. Journal der Deutschen Dermatologischen Gesellschaft. 2014; 12(3):188-210. https://doi.org/10.1111/ddg.12245

2. Homei A, Worboys M. 1. Introduction. Fungal disease in Britain and the United States 1850-2000: Mycoses and Modernity. Springer; 2013. p. 6. https://doi.org/10.1057/9781137377029_1

3. Qumri AMHBN. Ghina Muna urdu translation as Minhajiul Ilaj, CCRUM, Ministry of AUYSH. p. 481-2.

4. Tabri AHAbR. Firdous ul Hikmat (Urdu Translation) by Hakim Rasheed Ashraf Nadvi. CCRUM. p. 640.

5. Tib AMIZa-R. Alhavi fit, Urdu translation by S A Jafr and M Y Siddiqui, Volume 23rd part. Saba Publication. p. 46-52.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3